|
HY-B0144-5mg
|
MedChemexpress LLC
|
Pitavastatin (Calcium) [CAS 147526-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B0144-50mg
|
MedChemexpress LLC
|
Pitavastatin (Calcium) [CAS 147526-32-7]
|
|
Cancer-programmed cell death
|
|
|
HY-B0144-1mL
|
MedChemexpress LLC
|
Pitavastatin (Calcium) [CAS 147526-32-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-B0144A-10mg
|
MedChemexpress LLC
|
Pitavastatin [CAS 147511-69-1]
|
|
Cancer-programmed cell death
|
|
|
HY-B0144A-5mg
|
MedChemexpress LLC
|
Pitavastatin [CAS 147511-69-1]
|
|
Cancer-programmed cell death
|
|
|
HY-D1421
|
MedChemexpress LLC
|
PKH 67 [CAS 257277-27-3]
|
|
|
|
|
HY-130481-100mg
|
MedChemexpress LLC
|
Propargyl-PEG4-acid [CAS 1415800-32-6]
|
|
Cancer-programmed cell death
|
|
|
HY-130481-25mg
|
MedChemexpress LLC
|
Propargyl-PEG4-acid [CAS 1415800-32-6]
|
|
Cancer-programmed cell death
|
|
|
HY-130481-50mg
|
MedChemexpress LLC
|
Propargyl-PEG4-acid [CAS 1415800-32-6]
|
|
Cancer-programmed cell death
|
|
|
HY-130481-1mL
|
MedChemexpress LLC
|
Propargyl-PEG4-acid [CAS 1415800-32-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-D0815-10mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-D0815-100mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-D0815-5mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-D0815-50mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-D0815-500mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-P1411-100ug
|
MedChemexpress LLC
|
Psalmotoxin 1 [CAS 880107-52-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-14649-1g
|
MedChemexpress LLC
|
Retinoic acid [CAS 302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-14649-100mg
|
MedChemexpress LLC
|
Retinoic acid [CAS 302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-14649-500mg
|
MedChemexpress LLC
|
Retinoic acid [CAS 302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-14649-1mL
|
MedChemexpress LLC
|
Retinoic acid [CAS 302-79-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-14649S4-5mg
|
MedChemexpress LLC
|
Retinoic acid-d5 [CAS 78996-15-3]
|
|
Cancer-programmed cell death
|
|
|
HY-112136-10mg
|
MedChemexpress LLC
|
TAO Kinase inhibitor 1 [CAS 850467-66-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112136-100mg
|
MedChemexpress LLC
|
TAO Kinase inhibitor 1 [CAS 850467-66-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112136-5mg
|
MedChemexpress LLC
|
TAO Kinase inhibitor 1 [CAS 850467-66-2]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-112136-50mg
|
MedChemexpress LLC
|
TAO Kinase inhibitor 1 [CAS 850467-66-2]
|
|
Neuroscience-Neuromodulation
|
|
